PMC:7558914 / 1091-1328
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 40 | 206-214 | Species | denotes | patients | Tax:9606 |
| 51 | 26-44 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 52 | 49-68 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 53 | 101-119 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 54 | 121-133 | Chemical | denotes | azithromycin | MESH:D017963 |
| 55 | 139-158 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 68 | 227-236 | Disease | denotes | pneumonia | MESH:D011014 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T3 | 227-236 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 0-237 | Sentence | denotes | Different combinations of hydroxychloroquine and lopinavir/ritonavir (46.7%) and triple therapy with hydroxychloroquine, azithromycin, and lopinavir/ritonavir (40%) were the most recommended treatments for patients with severe pneumonia. |